Navigation Links
DSM and LibraGen Sign Agreement to Co-Develop Transaminases for Production of Chiral Amines
Date:9/15/2008

iences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost EUR 8.8 billion and employs some 23,000 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: http://www.dsm.com.

Forward-looking statements

Any forward-looking statements contained in this press release that involve inherent risks and uncertainties are based on current expectations, estimates and projections of the management of DSM and information currently available. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update any statements contained in this press release.

For further information please contact:

DSM Pharmaceutical Products

Guy Tiene

Director, Marketing & Communications

Tel: +1-973-257-8160

guy.tiene@dsm.com

DSM Pharmaceutical Products

Oliver May

Competence Manager Biocatalysis

Tel: +31 (46) 4760551

Oliver.May@DSM.com

LibraGen

Renaud Nalin

Chief Executive Officer

Tel: +33 562 193 290

nalin@libragen.com

LibraGen

Fabrice Lefevre

Chief Scientific Officer

Tel: +33 562 193 297

f.lefevre@libragen.com


'/>"/>
SOURCE DSM Pharmaceutical Products
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
7. Lilly and Glenmark Pharmaceuticals Announce License Agreement
8. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
9. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
10. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
11. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015  BD Life Sciences, a segment of ... BDX ), a leading global medical technology company, ... enabling high-resolution biology, today announced that they will ... multiplexed cell isolation and single-cell gene expression analysis. ... BD FACS™ single-cell sorting instrumentation and software with ...
(Date:2/26/2015)... ASHKELON, Israel , Feb. 26, 2015 ... developer of the GlucoTrack ® model DF-F, a ... Dr. Lutz Heinemann , Ph.D., will head its ... key opinion leaders in the field of Diabetes research, ... Heinemann , Ph.D has been Chief Executive Officer and ...
(Date:2/26/2015)... People with psoriasis and their health ... in research that aims to improve treatments and ... registry begins recruiting patients in 2015. ... Psoriasis Foundation and Corrona, LLC, will initially track ... biologic medication by Novartis Pharmaceuticals for moderate-to-severe psoriasis. ...
Breaking Medicine Technology:BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3
... 25, 2011 Angelini Labopharm, LLC, today ... Company.  Formerly Senior Vice President, Sales and Marketing for ... subsidiary, Labopharm USA, Inc., Ms. Heino,s primary focus will ... the commercialization of OLEPTRO™, as well as to explore ...
... N.J., Jan. 25, 2011 Johnson & Johnson (NYSE: ... the fourth quarter of 2010, a decrease of 5.5% as ... 5.1% and the negative impact of currency was 0.4%. Domestic ... operational decline of 2.3% and a negative currency impact of ...
Cached Medicine Technology:Angelini Labopharm Confirms Appointment of Mary Anne Heino as President 2Angelini Labopharm Confirms Appointment of Mary Anne Heino as President 3Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 2Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 3Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 4Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 5Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 6Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 7Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 8Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 9Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 10Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 11Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 12Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 13Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 14
(Date:2/27/2015)... Over 440,000 patients die annually as a result of ... jet airplanes crashing each day. Now more than ever before, ... to do all they can to stay safe. , Through ... U.S. Surgeon General, discusses the importance of safer hospitals. “It’s ... safety issues to ensure that all our patients are in ...
(Date:2/27/2015)... 2015 Jupiter Medical Center and The ... Sinai Heart New York at Jupiter Medical Center, to ... Florida. , “This innovative collaboration with Mount Sinai ... unparalleled health care in our very own backyard,” said ... Jupiter Medical Center. “This kind of innovative thinking will ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Muscular ... of Biomedical Engineering at Duke University, recently announced ... boys and young men with Duchenne muscular dystrophy ... Nature Communications, and Gersbach will discuss their implications ... March 11-14 in Washington, D.C. , Background: ...
(Date:2/27/2015)... Ticket Down is a reputable source for authentic ... Act 3: Hollywood" Tour. This tour is in support of ... the charts at #1 and went on to become a ... artist will begin touring in conjunction with "Act 1: Hometown" ... as San Antonio, New Orleans, Tallahassee, Nashville and Salt Lake ...
(Date:2/27/2015)... Over 440,000 patients die each year as a result ... readers on how they can take control of their health, ... guide to educate and inspire readers to learn more about ... with tips on topics ranging from hospital to anesthesia safety. ... print publication. He recently spoke to Mediaplanet about ...
Breaking Medicine News(10 mins):Health News:Dr. Richard Carmona, the 17th U.S. Surgeon General, and IntelliCentrics Raise Awareness in Mediaplanet’s “Patient Safety” Campaign 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 2Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 3Health News:Safe and Sound: Improving Patient Outcomes through Mediaplanet’s “Patient Safety” Campaign 2
... It has been widely observed that only a small ... most advanced form of alcoholic liver disease (ALD); the ... is not known. The present study from Spain, ... genetic polymorphisms that determine levels of glutathione-S-transferases (GST) relate ...
... in extended family groups of up to 20 individuals. ... and a number of subordinate individuals, typically descendants of ... Hacklnder of the Institute of Wildlife Biology and Game ... and Walter Arnold of the Research Institute of Wildlife ...
... emissions increased by a record 5.9 per cent in ... Financial Crisis (GFC), according to scientists working with the ... published its annual analysis in the journal Nature ... GFC on emissions has been short-lived owing to strong ...
... are associated with better delivery of preventive health care ... care practices are funded, states an article in ... Although there is significant interest around the world in ... health care -- and disease prevention, there is a ...
... The American Society of Clinical Oncology (ASCO) today released ... Against Cancer, an independent review of the advances in ... patient care this year. The report also identifies ... from experts on where the future of cancer care ...
... HealthDay Reporter , MONDAY, Dec. 5 (HealthDay ... have a nearly three times higher risk of having ... in Denmark used national birth data that included nearly ... 2006 to 428,000 women. Using a national prescription drug ...
Cached Medicine News:Health News:Hanging with the boys - female Alpine marmots benefit from a bit of pre-natal testosterone 2Health News:Global Carbon Project annual emissions summary 2Health News:Funding models not associated with better preventive care delivery 2Health News:American Society of Clinical Oncology issues annual report on progress against cancer 2Health News:American Society of Clinical Oncology issues annual report on progress against cancer 3Health News:Fetal Exposure to Epilepsy Drug Might Raise Autism Risk: Study 2Health News:Fetal Exposure to Epilepsy Drug Might Raise Autism Risk: Study 3
... OEC announced another imaging first with the ... Mobile Imaging System. This breakthrough platform in ... 1K imaging resolution technology available in a ... a new standard for mobile imaging systems ...
... The PS Medical Delta valve is ... fluid (CSF) and maintain intraventricular pressure ... regardless of patient position. The normally ... response to positive ventricular pressure. Working ...
...
... Disposable bars made of silver/silver chloride have ... for easy separation into two individual tabs. ... (page 17). Bar dimensions: 4 cm (1.6 ... Each 200-count package contains 50 individually sealed ...
Medicine Products: